A Comparative Molecular Field (CoMFA) Studies on Carbonic Anhydrase Inhibitor hCA IX-Tumor-Associated (Hypoxia)

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|9|877-883

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.9, 2011-11, pp. : 877-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII

By  

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3246-3254

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII

By  

Current Medicinal Chemistry, Vol. 17, Iss. 15, 2010-05 ,pp. : 1516-1526

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors: CA IX selective inhibitors incorporating aromatic or heterocyclic sulfonamide

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 233-236

Informa Healthcare

Access to resources Recommend Favorite

Histopathological Determinants of Tumor Resistance: A Special Look to the Immunohistochemical Expression of Carbonic Anhydrase IX in Human Cancers

By  

Current Medicinal Chemistry, Vol. 21, Iss. 14, 2014-05 ,pp. : 1569-1582

Bentham Science Publishers

Access to resources Recommend Favorite

CoMFA and CoMSIA Studies of 1,2-dihydropyridine Derivatives as Anticancer Agents

By  

Medicinal Chemistry, Vol. 8, Iss. 3, 2012-05 ,pp. : 372-383

Bentham Science Publishers

Access to resources Recommend Favorite